Other OTC - Delayed Quote USD

Cell MedX Corp. (CMXC)

0.0320 0.0000 (0.00%)
At close: April 25 at 11:55 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
5/31/2023
5/31/2022
5/31/2021
5/31/2020
Total Revenue
0.0740
2.7620
6.0650
6.7620
95.8240
Cost of Revenue
0.5450
2.2790
2.0320
3.2400
10.2360
Gross Profit
-0.4710
0.4830
4.0330
3.5220
85.5880
Operating Expense
215.6930
448.1410
675.7260
686.1090
1,123.9390
Operating Income
-216.1640
-447.6580
-671.6930
-682.5870
-1,038.3510
Net Non Operating Interest Income Expense
-68.2650
-47.3840
-25.6860
-32.0200
-21.0690
Other Income Expense
--
--
--
-196.2290
-33.2780
Pretax Income
-96.9120
-495.0420
-697.3790
-910.8360
-1,092.6980
Net Income Common Stockholders
-96.9120
-495.0420
-697.3790
-910.8360
-1,092.6980
Diluted NI Available to Com Stockholders
-96.9120
-495.0420
-697.3790
-910.8360
-1,092.6980
Basic EPS
-0.00
-0.01
-0.01
-0.02
-0.02
Diluted EPS
-0.00
-0.01
-0.01
-0.02
-0.02
Basic Average Shares
102,263.6430
62,923.0630
62,798.8170
58,763.7960
53,477.5150
Diluted Average Shares
102,263.6430
62,923.0630
62,798.8170
58,763.7960
53,477.5150
Total Expenses
216.2380
450.4200
677.7580
689.3490
1,134.1750
Net Income from Continuing & Discontinued Operation
-96.9120
-495.0420
-697.3790
-910.8360
-1,092.6980
Normalized Income
-284.4290
-495.0420
-697.3790
-714.6070
-1,059.4200
Interest Expense
--
--
--
--
21.0690
Net Interest Income
-68.2650
-47.3840
-25.6860
-32.0200
-21.0690
EBIT
-28.6470
-447.6580
-671.6930
-682.5870
-1,038.3510
EBITDA
-28.6470
-447.6580
-670.5480
-680.1530
-1,036.5050
Reconciled Cost of Revenue
0.5450
2.2790
2.0320
3.2400
10.2360
Reconciled Depreciation
--
--
1.1450
2.4340
1.8460
Net Income from Continuing Operation Net Minority Interest
-96.9120
-495.0420
-697.3790
-910.8360
-1,092.6980
Total Unusual Items Excluding Goodwill
187.5170
--
--
-196.2290
-33.2780
Total Unusual Items
187.5170
--
--
-196.2290
-33.2780
Normalized EBITDA
-216.1640
-447.6580
-670.5480
-483.9240
-1,003.2270
5/31/2020 - 8/29/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

UTRS Minerva Surgical, Inc.
0.0010
0.00%
 
NXL Nexalin Technology, Inc.
1.4400
+3.60%
 
MOTS Motus GI Holdings, Inc.
0.0810
+1.25%
 
SYK Stryker Corporation
335.61
-0.46%
 
BSX Boston Scientific Corporation
73.17
-0.12%